Opioid free Anesthesia versus Balanced Anesthesia with Fentanyl for Laparoscopic Bariatric Surgeries
Not Applicable
Not yet recruiting
- Conditions
- Anaesthesia
- Registration Number
- PACTR202203767098081
- Lead Sponsor
- Faculty of Medicine Tanta University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
adult patients of both sexes,
-aged 18-60 years old,
-classified by the American society of anesthesiologists as ASA II and III
Exclusion Criteria
-Patients refusal,
- renal or hepatic insufficiency,
-chronic opioid or beta blocker use
- known allergy to study drugs
- patients with atrioventricular block type II & III.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of dexmedetomidine in opioid-free anesthesia for bariatric surgery?
How does opioid-free anesthesia with dexmedetomidine compare to fentanyl-based balanced anesthesia in postoperative outcomes for laparoscopic bariatric procedures?
Are there specific biomarkers that predict patient response to dexmedetomidine versus fentanyl in bariatric surgical anesthesia?
What are the potential adverse events associated with dexmedetomidine use in opioid-free anesthesia for morbid obesity patients undergoing laparoscopic surgery?
What combination approaches or alternative analgesics are being explored as competitors to dexmedetomidine in opioid-free anesthesia for bariatric surgery?